Free Trial
→ Trump set to Boost Social Security Checks by 400%? (From InvestorPlace) (Ad) Free NKGN Stock Alerts

NKGen Biotech (NKGN) SEC Filings & 10K Form

NKGen Biotech logo
$0.17 0.00 (0.00%)
As of 08/6/2025
Compare

Recent NKGen Biotech SEC Filings

Export to Excel
DateFilerForm TypeView
07/17/2025
3:33 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2025
12:25 PM		Nasdaq Stock Market LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Form 25-NSE
07/16/2025
4:25 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2025
7:00 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
11:11 AM		CFIC-2015 NV Family Investments, LLC (Reporting)
Cherng Andrew Jin-Chan (Reporting)
CHERNG PEGGY (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
11:12 AM		CFIC-2015 NV Family Investments, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Form SCHEDULE 13D
05/20/2025
7:00 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
11:29 AM		METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Form SCHEDULE 13G/A
05/08/2025
7:06 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
4:09 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form NT 10-K
03/11/2025
8:00 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
12:45 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 424B3
03/04/2025
5:34 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/28/2025
4:46 PM		NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
PATHSTONE FAMILY OFFICE, LLC (Filed by)
Form SCHEDULE 13G
02/25/2025
3:30 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
9:34 AM		METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Form SCHEDULE 13G/A
02/03/2025
7:00 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form DEF 14A
01/08/2025
4:29 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
3:54 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:00 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
6:20 PM		Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:01 PM		Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:23 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:55 PM		Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:56 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:56 PM		Klowden Michael (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:56 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:10 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
3:30 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
4:22 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
3:01 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
5:06 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
5:05 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
4:25 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:00 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:30 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
5:09 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
3:30 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
4:16 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/11/2024
4:26 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
6:00 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
GENIUS Act: Cancel Your Money? (Ad)

A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.

Get the free info kit with 3 strategies to sidestep digital dollar control.
08/30/2024
7:00 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
5:45 PM		CFIC-2015 NV Family Investments, LLC (Reporting)
Cherng Andrew Jin-Chan (Reporting)
CHERNG PEGGY (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/22/2024
4:22 PM		CFIC-2015 NV Family Investments, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Form SC 13G
08/22/2024
3:42 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:NKGN) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Crypto 101 Media | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Protect Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
Sell this, buy that
What you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...
InvestorPlace | Sponsored
Amazon’s big Bitcoin embarrassment
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...
Brownstone Research | Sponsored
Altucher: Trump’s Great Gain is starting
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...
Paradigm Press | Sponsored
Critical AI announcement set to ignite AI 2.0
A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...
Timothy Sykes | Sponsored
Trump’s new nightmare
According to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...
Porter & Company | Sponsored